Picture loading failed.

Pre-Made Fulranumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Fulranumab is a monoclonal antibody against nerve growth factor. It was designed for the treatment of pain.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-226-1mg 1mg 3090
GMP-Bios-ab-226-10mg 10mg Inquiry
GMP-Bios-ab-226-100mg 100mg Inquiry
GMP-Bios-ab-226-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Fulranumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody
INN Name Fulranumab
TargetNGF
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusDiscontinued
100% SI StructureNone
99% SI Structure4m6o:HL
95-98% SI StructureNone
Year Proposed2010
Year Recommended2011
CompaniesJanssen Pharmaceuticals;Janssen Research & Development;Takeda;Amgen
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedPain;Back pain;Cancer pain;Musculoskeletal pain;Neuropathic pain
Development TechAbgenix XenoMouse